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Correction of Dark Coloration of the Lower Eyelid Skin 
with Nanofat Grafting
INTRODUCTION
Periorbital hyperpigmentation (POH), generally called “dark cir-
cle,” is a condition characterized by relatively dark coloration of 
the periorbital eyelids. It is a common worldwide problem, which 
makes a person appear tired, sad, and aged. Although this condi-
tion does not cause physical morbidity, it can pose a substantial 
cosmetic problem and, eventually, affect the quality of life of the 
effected individual.
 A number of factors can cause dark circles around the eyes. 
One cause is excessive pigmentation due to dermal melanocytosis. 
This can be congenital or occur secondary to such conditions as 
atopic or allergic contact dermatitis [1]. Another common cause 
of dark circle is a thin, translucent lower eyelid skin overlying the 
orbicularis oculi muscle. Transparent eyelid skin allows visualiza-
tion of the underlying subcutaneous vascular plexus or vascula-
ture within the muscle [2]. Shadowing due to skin laxity and tear 
trough is another cause of infraorbital dark circle [3]. This can 
worsen with time because of age-related loss of subcutaneous fat 
and hollowness of the periorbital area. 
 Therapeutic modalities for dark circles differ depending on the 
primary causative factor. Although a number of treatment options 
are available, autologous fat transplantation is known to be effec-
tive, especially for patients with the vascular type of dark circle [4]. 
Injecting fat between the skin and muscle can be expected to act 
as a barrier that prevents visualization of hypervascularity within 
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Background A number of factors can cause dark circles around the eyes including 
excessive pigmentation, thin and translucent lower eyelid skin overlying the orbicu-
laris oculi muscle, and shadowing due to skin laxity and tear trough. Autologous fat 
graft is an effective method for the treatment of lower lid dark circles, but irregulari-
ties caused by leaving visible lumps of the fat can occur. Tonnard et al. suggested 
‘nanofat’ grafting and introduced its characteristics and clinical applications. The au-
thors used their nanofat grafting to correct lower eyelid dark circles.
Methods Nanofat grafting was performed in 19 patients for dark lower eyelids. The 
grafts were injected into subdermal layer using blunt cannula. Microfat grafting with 
nasojugal fold was performed to all the patients. Among them, 18 patients received 
transconjunctival fat removal at the same time. 
Results All the patients showed much improvement from preoperative dark color-
ation. There were no visible lumps of fat, contour irregularities, or fat necrosis. Post-
operative edema and ecchymosis were minimal.
Conclusions Nanofat grafting methods provide a good alternative for correcting 
dark circles by augmenting thin skin with lower complications. This simple, cost ef-
fective procedure is suitable for correction of dark circles and various skin rejuvena-
tion purposes.
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the muscle. One of possible complications of autologous fat graft-
ing is the irregularity caused by visible lumps. We have encoun-
tered several complicated cases of lumped fat, which required re-
moving the fat through an infraciliary incision.
 In 2013, Tonnard et al. described a nanofat grafting technique 
[5]. These authors applied a mechanical emulsification process to 
achieve much finer fat particles. In contrast to the typical fat graft-
ing method, which acts primarily by producing a physical volume 
effect, nanofat grafting may act primarily by the activity of trans-
planted stem cells.
 The purpose of this study is to evaluate the effectiveness of the 
nanofat grafting technique in correcting infraorbital dark circles.
METHODS
Patients
Nineteen patients with dark circles due to increased vascularity 
and translucency of the skin were included. They underwent 
nanofat grafting for dark lower eyelids from December 2013 to 
March 2014 at a single clinic. Microfat grafting of the nasojugal 
fold was performed simultaneously in all patients. Eighteen pa-
tients also underwent transconjunctival fat removal during the 
same operation. The patients included 1 man and 18 women, 
aged 22 to 41 years old (mean, 30 years old). The mean follow-up 
period was 2.5 months, ranging from 2 to 4 months.
Operation methods
Fat was aspirated from the medial thigh or lower abdomen using 
the Coleman method. After centrifugation at 3,000 rpm for 3 
minutes, the lipoaspirate was mechanically emulsified. Emulsifi-
cation of the fat was achieved by shifting the fat between two 
1-mL syringes connected to each other by a female-to-female Lu-
er-Lock connector (Fig. 1). This differs from the technique intro-
duced by Tonnard et al., in which 10-mL syringes were used [5]. 
After more than 30 transfers between syringes, the fat changed 
into an emulsion. To determine whether the fat was ready to in-
ject, we used a 20 gauge blunt cannula, mounted into a 1-mL sy-
ringe. If there was no resistance when we gently pushed the piston 
of the 1-mL syringe, the emulsification process was deemed com-
plete. Otherwise, we performed 30 to 50 more transfers and re-
peated the determination procedure. The emulsified fatty liquid 
was filtered over the sterile nylon cloth and the effluent was col-
lected in a sterile recipient syringes.
 First, microfat grafting was performed in part of the nasojugal 
groove. This was followed by nanofat grafting toward the upper 
part of the groove. The nanofat grafts were injected into the sub-
dermal layer using a 20-gauge blunt cannula, inserted through a 
small incision approximately 2 cm below the lateral canthus. In-
jection continued until a smooth contour with the microfat-graft-
ed area was achieved. The mean volume of microfat graft for each 
eyelid was 1.6 mL (range, 0.5–3.3 mL). 
Assessment of outcomes
Standardized photographs were taken at baseline and at 2 months 
after treatment. All patients were clinically evaluated using these 
serial photographs by 10 plastic surgeons, who were blinded to the 
type of procedure performed. The improvement in pigmentation 
and skin texture was assessed using a grading scale: 0, <25% im-
provement (poor); 1, 26–50% improvement (fair); 2, 51–75% im-
provement (good); 3, 75–90% improvement (excellent); and 4, 
91–100% improvement (complete). Patients also assessed their 
satisfaction on a quartile scale: 0, not satisfied at all; 1, slightly sat-
isfied; 2, moderately satisfied; and 3, very satisfied. Postoperative 
complications, including ecchymosis, pain, edema, and erythema, 
were evaluated during the follow-up period.
RESULTS
All patients were evaluated for improvement using photographic 
evidence and all showed much improvement from their preopera-
tive degree of dark coloration. The patients exhibited a mean im-
provement of 70% (mean grading scale, 2.4) for physician objec-
tive improvement scores. Most patients exhibited improvement in 
the infraorbital darkening and skin texture of the lower eyelids 
Fig. 1. Emulsification of the fat was achieved by shifting the fat be-
tween two 1 cc syringes connected to each other by a female-to-fe-
male Luer-Lok connector.
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Fig. 2. (A) Preoperative view of 35-year-old woman who underwent nanofat grafting and transconjunctival fat removal for correction dark low-
er eyelids. (B) Postoperative 2-month view of the patient.
A B
Fig. 3. (A) Preoperative view of 22-year-old woman who underwent nanofat grafting and transconjunctival fat removal for correction dark low-
er eyelids. (B) Postoperative 2-month view of the patient.
(Fig. 2-5). However, none of the patients showed 100% improve-
ment, which suggests that multiple factors contributed to the in-
fraorbital dark circles and absorption of the injected nanofat. Most 
patients were satisfied with their improvement. The mean patient 
satisfaction score was 2.0 (moderately satisfied). There were no 
visible lumps of fat, contour irregularities, or fat necrosis. Postop-
A B
Fig. 4. (A) Preoperative view of 26-year-old woman who underwent nanofat grafting and transconjunctival fat removal for correction dark low-
er eyelids. (B) Postoperative 2-month view of the patient.
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erative erythema, pain, edema, and ecchymosis were minimal and 
rarely persisted for more than 72 hours. 
DISCUSSION
Infraorbital dark circles affect individuals of both sexes, all races, 
and a wide range of ages. The condition causes considerable cos-
metic concern and negatively impacts emotional well-being. Sev-
eral factors are known to cause dark circles, including excessive 
pigmentation of the skin, thin and translucent lower eyelid skin 
overlying the orbicularis oculi muscle, and shadowing due to skin 
laxity and tear trough.
 The most appropriate treatment modality differs depending on 
the main causative factor of the dark circle. Topical skin lightening 
agents are the mainstay of the treatment for hyperpigmentation. 
Agents commonly used for hyperpigmentation include hydroqui-
none, retinoic acid, mequinol, azelaic acid, and corticosteroids. 
Various combination therapies of these topical agents have been 
used to increase their efficacy while reducing side effects [6]. Che-
mical peeling, a process of removing the epidermis or upper der-
mis with chemical agents, is another option for patients with hy-
perpigmentation [7,8]. Lasers are also appropriate options, not 
only for hyperpigmentation but also for skin resurfacing [3,9,10]. 
Skin resurfacing with lasers is indicated for dark circles due to skin 
laxity and tear trough. Lasers used this purpose include the pulsed 
dye laser, diode laser, and 1,064-nm and 1,320-nm Nd:YAG lasers 
[2].
 However, the aforementioned modalities are not effective for 
patients with dark circles due to thin, translucent skin. For pa-
tients with this type of dark circle, autologous fat transplantation 
has been reported as an effective method [4]. The vascular type of 
dark circle, due to a combination of transparency of the overlying 
skin and dense dermal vascularity, is the most common form of 
dark circle in Asian patients [10]. This may explain why topical 
agents, such as steroid or skin lightening creams, frequently fail to 
treat dark circles in this ethnic group. 
 For patients with light-colored, thin skin, soft tissue filler can be 
considered as an alternative treatment option, as the effect of au-
tologous fat transplantation arises at least partially from the tissue 
acting as a barrier to reduce the translucency of the thin skin. 
However, soft tissue fillers have been reported to cause complica-
tions, including worsened pigmentation, a bluish color change, 
and increased vascularity. Lumps or contour irregularities are also 
common complications of soft tissue fillers, especially for thin 
eyelid skin. Goldberg and Fiaschetti reported that patients who 
were unhappy with soft tissue filler injection to the periorbital 
area tended to have thinner skin, which is more vulnerable to de-
veloping increased vascularity, bruising, or contour irregularities 
[11]. This is why fat grafting, which is readily available, safe, and 
completely biocompatible, is preferred to soft tissue fillers for dark 
circles accompanying thin eyelid skin.
  According to Tonnard’s study, mechanically processing fat 
when producing nanofat completely disrupts the adipose tissue 
structure [5]. Thus, grafting with nanofat usually does not have a 
prominent direct volume-adding effect. Instead, the major effect 
of nanofat injection appears to relate to stem cell activity. 
 In the current study, nanofat grafting combined with microfat 
grafting produced satisfactory results in treating lower eyelid dark 
circles. Microfat grafting at the nasojugal folds compensated for 
the lack of volumetric effects of the nanofat grafting technique, 
and nanofat grafting at the lower eyelids improved the dark circles 
effectively, without any noticeable irregularity. This technique 
produces effects that are similar to those achieved by injecting pu-
rified stromal vascular fraction, but without the complicated tech-
nique or expensive laboratory equipment required for the latter. 
As well, the skin rejuvenating effects from stem cell activity are 
augmented by the fat graft acting as a soft tissue filler, to produce 
the final effect.
 The nanofat grafting technique introduced by Tonnard uses 
very thin injection needles. Although there have been many stud-
A B
Fig. 5. (A) Preoperative view of 29-year-old woman who underwent nanofat grafting and transconjunctival fat removal for correction dark low-
er eyelids. (B) Postoperative 2-month view of the patient.
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Fig. 6. A mock injection with nanofat (upper) and microfat (lower). 
Nanofat could make more regular, finer particles of fat than microfat 
with the same cannula.
ies of microfat grafting techniques using thin cannulas, Tonnard 
et al. used even thinner needles, as small as 27 gauge [5]. By con-
trast, we used a blunt cannula instead of a sharp injecting needle. 
In Tonnard’s cases, whitish discoloration remained for 1 month 
postoperatively and eyelid skin was erythematous for 3 months 
after the procedure. We considered these recovery times to be too 
long for actual clinical cases, so we decided to avoid intradermal 
needle injections.
 Although injected with a blunt cannula, the advantage of nano-
fat was apparent during the transferring procedure. In a mock in-
jection, mechanically processed nanofat produced more regular 
and finer particles of fat than microfat using the same cannula 
(Fig. 6). In our practice, we have had patients with visible lumps 
following microfat grafting in the lower eyelids, which required 
removal of the grafted fat through an infraciliary incision in some 
cases. However, we have never observed irregularities using the 
nanofat technique.
 Our final results were satisfactory, but we cannot be sure that 
they were as good as those produced by Tonnard et al. [5]. It is 
possible that better results could be obtained if the procedures in-
cluded intradermal fat injection. However, we can expect the vol-
ume augmentation effect minutely comparing to Tonnard’s nano-
fat grafting. Further studies including histological examination 
may help address this issue.
 In conclusion, for patients with dark circles due to thin, translu-
cent eyelid skin, our nanofat grafting technique provided substan-
tial improvements. Unlike microfat grafting, which is complicated 
in some cases by postoperative irregularities of the eyelid skin, 
nanofat grafting rarely causes complications such as lumps or ir-
regularities. Our results suggest that the stem cell activity of the 
nanofat grafting technique has great potential as a treatment mo-
dality for skin rejuvenation in general, not only for the treatment 
of dark circles. This simple, cost effective procedure seems to be 
suitable for the correction of dark circles, and with further studies, 
nanofat technology will likely expand the indications for fat graft-
ing techniques.
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